New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 28, 2013
09:26 EDTBBRY, AFAM, GTIV, AMED, PFE, ABFS, SNY, BIIB, ACI, MCP, DNDN, ACN, LHCGOn The Fly: Pre-market Movers
HIGHER: Dendreon (DNDN), up 9.8% after getting positive EU opinion for Provenge drug... Arkansas Best (ABFS), up 10% after ABF Freight System employees represented by Teamsters ratify five-year national labor agreement... Molycorp (MCP), up 7.8% after SEC completes investigation with no enforcement action recommended... Arch Coal (ACI), up 8.9% after announcing will sell non-core Utah operations to Bowie Resources for $435M... Biogen (BIIB), up 5.8% after the European Medicines Agency granted Sanofi's multiple sclerosis drug Aubagio "new active substance" status. Sanofi, which also received a positive CHMP opinion for Lemtrada, up 1.5%... Pfizer (PFE), up 1% after boosting share buyback program by $10B. DOWN AFTER EARNINGS: BlackBerry (BBRY), down 23%... Accenture (ACN), down 9%... Nike (NKE), down 0.8%. ALSO LOWER: Home health agencies, including Amedisys (AMED), down 21%, Gentiva Health (GTIV), down 16%, Almost Family (AFAM), down 13%, and LHC Group (LHCG), down 12%, after the Centers for Medicare & Medicaid Services proposed 2014 reimbursement cuts.
News For BBRY;ACN;DNDN;MCP;ACI;BIIB;SNY;ABFS;PFE;AMED;GTIV;AFAM;LHCG From The Last 14 Days
Check below for free stories on BBRY;ACN;DNDN;MCP;ACI;BIIB;SNY;ABFS;PFE;AMED;GTIV;AFAM;LHCG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 15, 2014
08:15 EDTMCPMolycorp weakness creates buying opportunity, says DA Davidson
Subscribe for More Information
07:17 EDTACNFarnborough International to hold air show
Subscribe for More Information
07:04 EDTLHCGLHC Group to acquire Life Care Home Health for $10M in cash
Subscribe for More Information
06:46 EDTBBRYBlackBerry says many readers upbeat about new phone, Re/code reports
Subscribe for More Information
July 14, 2014
13:14 EDTMCPMolycorp mentioned positively at DA Davidson
12:06 EDTGTIVGentiva Health urges holders to take no action in response to Kindred offer
Subscribe for More Information
11:45 EDTBBRYStocks with call strike movement; BBRY SUNE
Subscribe for More Information
09:55 EDTGTIVHigh option volume stocks: PTEN MFRM GTIV SHPG IMMR
07:32 EDTGTIVKindred Healthcare increases all-cash tender offer for Gentiva to $16 per share
Subscribe for More Information
07:32 EDTGTIVKindred Healthcare increases all-cash tender offer for Gentiva to $16 per share
Subscribe for More Information
July 11, 2014
06:19 EDTBBRYBlackBerry to discontinue Scoreloop services as of December 1, WSJ reports
Subscribe for More Information
05:47 EDTMCPStocks with implied volatility movement; XRT MCP
Stocks with implied volatility movement; S&P Retail Index SPDR (XRT) 16, Molycorp (MCP) 118 according to iVolatility.
July 10, 2014
11:38 EDTMCPMolycorp mentioned positively at DA Davidson
Subscribe for More Information
July 9, 2014
17:02 EDTSNYRegeneron, Sanofi announce positive results from Phase 2b study of Dupilumab
Subscribe for More Information
12:00 EDTBBRYStocks with call strike movement; BBRY IGT
BlackBerry (BBRY) December 14 call option implied volatility decreased 5% to 54, International Game (IGT) October 19 call option implied volatility increased 3% to 51 according to IVolatility.
08:21 EDTGTIVGentiva Health sees FY14 EPS 85c-$1.15, consensus 90c
Gentiva reaffirmed its full-year 2014 outlook. Net revenues are expected to be in the range of $1.9B-$2.1B, Adjusted EBITDA is expected to be in the range of $177M-$195M. FY14 revenue consensus $1.97B. Gentiva's 2014 outlook includes the full-year impact of its Harden acquisition and the final 2014 Medicare home health and hospice reimbursement rates issued by the Centers for Medicare and Medicaid Services (CMS). The 2014 outlook excludes any ongoing losses from closed locations as the operations are wound down.
08:19 EDTGTIVGentiva Health sees Q2 adjusted EPS from cont. ops 33c, consensus 22c
Gentiva Health said the company anticipates results from continuing operations for Q2 to be equal to or in excess of the following, net revenues of $496M, adjusted EBITDA of $52M. Q2 revenue consensus $492.46M. The company said, "Gentiva’s continued momentum in the second quarter of 2014 reflects the success of the changes and strategic investments the Company has made over the past year. We strongly believe that today’s announcement provides further evidence that Gentiva’s strategy to increase stockholder value is working, reinforcing that Kindred’s offer grossly undervalues Gentiva and is not in the best interest of Gentiva stockholders.”
08:17 EDTGTIVGentiva Health says Kindred Healthcare offer 'substantially undervalues' company
Subscribe for More Information
07:23 EDTBIIBBiogen price target raised to $375 from $325 at RBC Capital
Subscribe for More Information
06:49 EDTPFEPfizer given dismissal of U.S. investor class action before trial, Reuters says
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use